Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0036690 (sepsis)
 59,461 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The authors report an eighth case of emphysematous perinephritis and a new case of emphysematous pyelonephritis. The general features of these two diseases and their similarities are described: middle aged diabetic women, clinical picture of sepsis, gas images projected over the renal area with delayed excretion on intravenous pyelography, computed tomography reveals the exact site of the emphysematous images (perinephritic and or intraparenchymal). Emphysematous perinephritis may be an early form of emphysematous pyelonephritis. Surgical drainage of the renal compartment allows conservative management at this early stage.
 ...
PMID:[Emphysematous pyelonephritis and perinephritis]. 261 67

The human immunoglobulin (SM-4300), which was developed by Travenol Laboratories, Inc. U.S.A., was used with antibiotics on 12 cases of severe surgical infectious disease. The method of administration and the evaluation of clinical effect of gammaglobulin (SM-4300) were made based upon the criteria of the SM-4300 study group. The clinical evaluation of the effect was classified in 5 grades; excellent, good, fair, poor and unknown. Three types of administration dose schedules were employed. Severe surgical infections were 3 cases of postoperative pneumonia, 3 cases of sepsis with pneumonia, 3 cases of peritonitis, 1 case of cholangitis, 1 case of sepsis with perinephritis and 1 case of subphrenic abscess. Bacterial and immunological examination were also performed before and after the administration of SM-4300. Evaluable cases were 10 cases out of 12 cases. Clinical effects of the administration of SM-4300 were evaluated as excellent in 1 case, good in 3, fair in 2 and poor in 4.
 ...
PMID:[An experience in the treatment of severe surgical infectious diseases with combination of antibiotics and human gammaglobulin (SM-4300)]. 407 26

The authors report the results from the follow-up of 14 patients with transplanted kidney, three out of them with a lethal end--mycotic sepsis--1, purulent peritonitis--1 and of transplant lung-syndrome--1. The rest (11-78,5%) were in a good condition during 1 year and 8 months to 6,5 years (an average of 4 years and 10 days by April 30, 1980). Eleven of the patients had their transplantations performed by Prof. Sumakov--Prof. Levizkii in Moscow and three--by Prof. Hamburger, Prof. Crosnier, Prof. Lacomb in Necker Hospital, Paris. During the follow-up period those 14 patients had the following complications: 15 acute crises of rejection, successfully coped, with residual phenomena in 4 of them; 10--uroinfections, 7--other infections, one mycotic sepsis and one purulent peritonitis with a lethal end; three with epidermic hepatitis, one--Herpes zoster, two bronchopneumonias, one perinephritis, 6--with arterial hypertension that necessitated binephrectomy in two, three patients with steroid diabetes--cured, four with aseptic osteonecrosis of the head of the femur, necessitating prosthesis of the femoral joint in one patient, 5--with surgical complications, corrected at the transplantation centers. Furthermore, one case with transplant lung-syndrome, successfully restored to health as reported by the authors. All those 11 patients with transplantations are in good health (one with a chronic rejection crisis) and 8 of them--work. The authors stress upon the follow-up of the renal patients with transplantation as an important step, consolidating the remote results of renal transplantation.
 ...
PMID:[Our experience with the dispensary observation and treatment of kidney transplant patients]. 701 86